News about

US FDA issues warning letter to Sun Pharma's Halol unit

Among other violations, the pharma major failed to thoroughly investigate any discrepancy or failure of a batch and failed to clean, maintain, sanitise, sterilise equipment and utensils at appropriate intervals

| 17/01/2023 | By |  1050

AstraZeneca partners with Australia-based LBT Innovations for new pharma product line

AstraZeneca will fund the development of the APAS Pharma analysis module and validate the final product for their processes
<br />

| 12/01/2023 | By |  740

Lupin, Exeltis bag reimbursement approval for NaMuscla in Spain

NaMuscla is Europe's first and only licensed product for this indication, and it will be commercialised in Spain by Lupin's partner Exeltis

| 11/01/2023 | By |  925

Sai Life Sciences in agreement to set up Schrodinger's first dedicated offshore research lab in India

The lab will be a dedicated facility for integrated discovery work streams including medicinal and synthetic chemistry, in vitro biology, and process chemistry

| 11/01/2023 | By |  1688

Sterling Pharma Solutions acquires Novartis' API manufacturing facility in Ireland

The 111-acre site, located near Cork, includes multiple commercial-scale production buildings, with a total vessel capacity of 175 cubic meters across over 30 reactor trains

| 11/01/2023 | By |  1361

Agilent Technologies to spend $725 M to double production capacity of therapeutic nucleic acids

Two new manufacturing lines—called Trains C and D—will be added to the company’s Frederick, Colorado, facility

| 11/01/2023 | By |  1000

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

The product is the generic version of Bumex 1 Injection, 0.25 mg/mL, of Validus Pharmaceuticals

| 11/01/2023 | By |  794

Lupin receives US FDA approval for Fesoterodine Fumarate extended-release tabs

The product will be manufactured at Lupin’s facility in Goa

| 09/01/2023 | By |  820

Pharmapack Europe to be held in Paris on Feb 1 and 2, 2023

Will introduce two new dedicated zones in 2024 namely packaging services and bio packaging

| 09/01/2023 | By |  952

Taiwan-based PharmaEssentia Corporation plans PharmaEssentia Innovation Research Center in greater Boston, Massachusetts area

PIRC will be equipped with a state-of-the-art lab featuring cutting-edge technology to support the identification and development of therapeutic opportunities

| 09/01/2023 | By |  974